BIO-RAD LABORATORIES, INC. (NYSE:BIO) Files An 8-K Results of Operations and Financial Condition

BIO-RAD LABORATORIES, INC. (NYSE:BIO) Files An 8-K Results of Operations and Financial Condition

Story continues below

ITEM 2.02 Results of Operations and Financial Condition

On February 23, 2017, Bio-Rad Laboratories, Inc. announced its
financial results for the quarter ended December 31, 2016. A copy
of the press release is furnished as Exhibit 99.1 to this report.
In accordance with General Instruction B.2 of Form 8-K, the
information in this Current Report on Form 8-K, including Exhibit
99.1 attached hereto, shall not be deemed to be filed for
purposes of Section 18 of the Securities Exchange Act of 1934, as
amended (the Exchange Act), or otherwise subject to the
liabilities of that section, and shall not be incorporated by
reference into any registration statement or other document filed
under the Securities Act of 1933, as amended, or the Exchange
Act, except as shall be expressly set forth by specific reference
in such filing.
ITEM 9.01 Financial Statements and Exhibits
Exhibit
Number
Description
99.1
Press release of Bio-Rad Laboratories, Inc. dated
February 23, 2017


About BIO-RAD LABORATORIES, INC. (NYSE:BIO)

Bio-Rad Laboratories, Inc. (Bio-Rad) is a manufacturer and distributor of life science research and clinical diagnostics products. The Company manufactures and supplies the life science research, healthcare, analytical chemistry and other markets with a range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components. Bio-Rad operates in two segments: Life Science and Clinical Diagnostics. The Company’s Life Science segment develops, manufactures, sells and services reagents, apparatus and instruments used for biological research. The Company’s Clinical Diagnostics segment develops, manufactures, sells and services automated test systems, informatics systems, test kits and specialized quality controls for the healthcare market. Bio-Rad sells over 8,000 products and services to a client base consisting of scientific research, healthcare, education and government customers around the world.

BIO-RAD LABORATORIES, INC. (NYSE:BIO) Recent Trading Information

BIO-RAD LABORATORIES, INC. (NYSE:BIO) closed its last trading session up +0.33 at 192.00 with 145,362 shares trading hands.

An ad to help with our costs